Response to: Comment on “Gut Microbiota as a Driver of Inflammation in Nonalcoholic Fatty Liver Disease”

by Stefano Bibbò, Maria Pina Dore, Giovanni Cammarota
Published 2018-01-01

Role of Probiotics in Helicobacter pylori Eradication: Lessons from a Study of Lactobacillus reuteri Strains DSM 17938 and ATCC PTA 6475 (Gastrus®) and a Proton-Pump Inhibitor

by Maria Pina Dore, Stefano Bibbò, Giovanni Mario Pes, Ruggero Francavilla, David Y. Graham
Published 2019-01-01

Gut Microbiota as a Driver of Inflammation in Nonalcoholic Fatty Liver Disease

by Stefano Bibbò, Gianluca Ianiro, Maria Pina Dore, Claudia Simonelli, Estelle E. Newton, Giovanni Cammarota
Published 2018-01-01

Increased Frequency of Immune Thrombocytopenic Purpura in Coeliac Disease and Vice Versa: A Prospective Observational Study

by Stefano Bibbò, Claudio Fozza, Giovanni Mario Pes, Rodrigo Rojas, Roberto Manetti, Maria Pina Dore
Published 2018-01-01

Role of Microbiota and Innate Immunity in Recurrent Clostridium difficile Infection

by Stefano Bibbò, Loris Riccardo Lopetuso, Gianluca Ianiro, Teresa Di Rienzo, Antonio Gasbarrini, Giovanni Cammarota
Published 2014-01-01

Fecal Microbiota Transplantation: Screening and Selection to Choose the Optimal Donor

by Stefano Bibbò, Carlo Romano Settanni, Serena Porcari, Enrico Bocchino, Gianluca Ianiro, Giovanni Cammarota, Antonio Gasbarrini
Published 2020-06-01

The impact of COVID-19 pandemic on IBD endoscopic procedures in a high-volume IBD Center

by Loris Riccardo Lopetuso, Franco Scaldaferri, Gianluca Ianiro, Stefano Bibbò, Carlo Romano Settanni, Alfredo Papa, Alessandro Armuzzi, Antonio Gasbarrini, Giovanni Cammarota
Published 2020-06-01

Fecal Microbiota Signatures in Celiac Disease Patients With Poly-Autoimmunity

by Stefano Bibbò, Marcello Abbondio, Rosangela Sau, Alessandro Tanca, Giovanna Pira, Alessandra Errigo, Roberto Manetti, Giovanni Mario Pes, Maria Pina Dore, Maria Pina Dore, Sergio Uzzau
Published 2020-07-01